Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 0.73 |
| ▸ | TSHR | P16473 | 3/20 | 0.73 |
| ▸ | BLM | P54132 | 3/20 | 0.73 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.73 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.73 |
| ▸ | MAPT | P10636 | 2/20 | 0.73 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.73 |
| ▸ | HTR1A | P08908 | 1/20 | 0.73 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.73 |
| ▸ | CNR1 | P21554 | 1/20 | 0.73 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.73 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.73 |
| ▸ | PPARG | P37231 | 7/20 | 0.60 |
| ▸ | MEN1 | O00255 | 3/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.60 |
| ▸ | ABCC8 | Q09428 | 2/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.60 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.60 |
| ▸ | ABCC3 | O15438 | 2/20 | 0.60 |
| ▸ | ABCC4 | O15439 | 2/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glisolamide SCHEMBL27735549 | 0.91 | CYP3A4 (0.62) | LMNATSHRBLMCYP2C9CYP3A4 | |
| Glisoxepide SCHEMBL28142826 | 0.87 | LMNA (0.57) | LMNATSHRBLMCYP2C9CYP3A4 | |
| Glipizide SCHEMBL17094 | 0.84 | TSHR (1.00) | LMNATSHRBLMCYP2C9CYP3A4 | |
| Glipizide SCHEMBL29366401 | 0.84 | TSHR (1.00) | LMNATSHRBLMCYP2C9CYP3A4 | |
| Glipizide SCHEMBL1536893 | 0.84 | TSHR (1.00) | LMNATSHRBLMCYP2C9CYP3A4 | |
| Glisoxepide SCHEMBL48892 | 0.84 | LMNA (0.55) | LMNATSHRBLMCYP2C9CYP3A4 | |
| Glipizide SCHEMBL27573879 | 0.83 | TSHR (0.98) | LMNATSHRBLMCYP2C9CYP3A4 | |
| Glipizide SCHEMBL27728874 | 0.83 | TSHR (0.98) | LMNATSHRBLMCYP2C9CYP3A4 | |
| Glipizide SCHEMBL28867262 | 0.83 | TSHR (0.98) | LMNATSHRBLMCYP2C9CYP3A4 | |
| Glipizide SCHEMBL2057153 | 0.83 | TSHR (0.98) | LMNATSHRBLMCYP2C9CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2578 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230322777-A1 | N1-Pyrazolospiroketone Acetyl-CoA Carboxylase Inhibitors | PFIZER INC. (US) | 2023-10-12 | — | — | US | claimed |
| US-10966993-B2 | Pharmaceutical composition comprising a sulfonylurea drug and preparation method thereof | JIANGSU AOSAIKANG PHARMACEUTICAL CO., LTD. (CN) | 2021-04-06 | — | — | US | claimed |
| US-20200353034-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DIABETES, CONTAINING ZINC SALT, CYCLO-HISPRO AND ANTIDIABETIC DRUG AS ACTIVE INGREDIENTS | NOVMETAPHARMA CO., LTD. (KR) | 2020-11-12 | — | — | US | claimed |
| US-10792280-B2 | Pharmaceutical composition comprising amodiaquine and anti-diabetes drug as effective ingredient for prevention or treatment of diabetes | NOVMETAPHARMA CO., LTD. (KR) | 2020-10-06 | — | — | US | claimed |
| EP-3698801-A2 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DIABETES, CONTAINING ZINC SALT, CYCLO-HISPRO AND ANTIDIABETIC DRUG AS ACTIVE INGREDIENTS | Novmetapharma Co., Ltd. (KR) | 2020-08-26 | — | — | EP | claimed |
| CN-111246859-A | Pharmaceutical composition for preventing or treating diabetes containing zinc salt, cyclodipeptide-histidine proline and antidiabetic drug as effective component | 诺麦塔制药有限公司 | 2020-06-05 | — | — | CN | claimed |
| EP-3556371-A1 | PHARMACEUTICAL COMPOSITION OF SULFONYLUREA DRUGS AND PREPARATION METHOD THEREFOR | Jiangsu Aosaikang Pharmaceutical Co., Ltd (CN) | 2019-10-23 | — | — | EP | claimed |
| EP-3498279-A1 | PHARMACEUTICAL COMPOSITION COMPRISING AMODIAQUINE AND ANTI-DIABETES DRUG AS EFFECTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF DIABETES | Novmetapharma Co., Ltd. (KR) | 2019-06-19 | — | — | EP | claimed |
| US-20190175583-A1 | PHARMACEUTICAL COMPOSITION COMPRISING AMODIAQUINE AND ANTI-DIABETES DRUG AS EFFECTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF DIABETES | NOVMETAPHARMA CO., LTD. (KR) | 2019-06-13 | — | — | US | claimed |
| US-10294225-B2 | N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors | PFIZER INC. (US) | 2019-05-21 | — | — | US | claimed |
| CN-1264302-A | Treatment of diabetes with thiazolidinediones and sulfonylureas | SMITHKLINE BEECHAM PLC (GB) | 2000-08-23 | — | — | CN | claimed |
| CN-1263467-A | Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor | SMITHKLINE BEECHAM PLC (GB) | 2000-08-16 | — | — | CN | claimed |
| WO-2000028989-A1 | PHARMACEUTICAL COMPOSITION FOR MODIFIED RELEASE OF AN INSULIN SENSITISER AND ANOTHER ANTIDIABETIC AGENT | SMITHKLINE BEECHAM P.L.C. (GB) | 2000-05-25 | — | — | WO | claimed |
| EP-1001784-A1 | TREATMENT OF DIABETES WITH THIAZOLIDINEDIONE, INSULIN SECRETAGOGUE AND ALPHA GLUCOSIDASE INHIBITOR | SMITHKLINE BEECHAM PLC (GB) | 2000-05-24 | — | — | EP | claimed |
| EP-1001783-A1 | TREATMENT OF DIABETES WITH THIAZOLIDINEDIONE, INSULIN SECRETAGOGUE AND DIGUANIDE | SMITHKLINE BEECHAM PLC (GB) | 2000-05-24 | — | — | EP | claimed |
| WO-2000027434-A1 | COMBINATIONS COMPRISING A BETA-AGONIST AND A FURTHER ANTIDIABETIC AGENT | SMITHKLINE BEECHAM P.L.C. (GB) | 2000-05-18 | — | — | WO | claimed |
| EP-0998291-A1 | TREATMENT OF DIABETES WITH THIAZOLIDINEDIONE AND SULPHONYLUREA | SMITHKLINE BEECHAM PLC (GB) | 2000-05-10 | — | — | EP | claimed |
| WO-1999003477-A1 | TREATMENT OF DIABETES WITH THIAZOLIDINEDIONE, INSULIN SECRETAGOGUE AND DIGUANIDE | SMITHKLINE BEECHAM P.L.C. (GB) | 1999-01-28 | — | — | WO | claimed |
| WO-1999003478-A1 | TREATMENT OF DIABETES WITH THIAZOLIDINEDIONE, INSULIN SECRETAGOGUE AND ALPHA GLUCOCIDASE INHIBITOR | SMITHKLINE BEECHAM P.L.C. (GB) | 1999-01-28 | — | — | WO | claimed |
| WO-1999003476-A1 | TREATMENT OF DIABETES WITH THIAZOLIDINEDIONE AND SULPHONYLUREA | SMITHKLINE BEECHAM PLC (GB) | 1999-01-28 | — | — | WO | claimed |